Three step high-dose chemotherapy in poor prognosis non-Hodgkin lymphoma.

被引：0
|
作者：
Ballestrero, A
Clavio, M
Ferrando, F
Secondo, V
Basta, P
Gonella, R
Garuti, A
Miglino, M
Pierri, I
Canepa, L
Beltrami, G
Vallebella, E
Ghio, R
Gobbi, M
Patrone, F
机构：
[1] Univ Genova, Sez Oncol & Ematol DIML, Genoa, Italy
[2] OC Galliera, Div Med, Genova, Italy
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
613
引用
收藏
页码：S177 / S177
页数：1
相关论文
共 50 条
  • [1] High-dose sequential chemotherapy in refractory Hodgkin's and non-Hodgkin's lymphoma.
    Oyan, B
    Koc, Y
    Kansu, E
    BLOOD, 2002, 100 (11) : 471B - 471B
  • [2] High-dose Chemotherapy (HDC) with rituximab and autologous stem cell support in patients with poor prognosis non-Hodgkin's lymphoma (NHL)
    Ptushkin, V
    Mheidze, D
    Larionova, V
    Zukov, N
    Andreeva, L
    Osmanov, E
    Chimishkyan, K
    BONE MARROW TRANSPLANTATION, 2002, 29 : S95 - S95
  • [3] Prevention of thrombocytopenia using thrombopoietin in high-dose cytarabine treatment of non-Hodgkin lymphoma.
    Huang, He
    Wang, Zhao
    Hong, Huangming
    Guo, Chengcheng
    Li, Xueying
    Zhang, Mengping
    Lin, Xiaoting
    Fang, Xiaojie
    Fu, Xiaohong
    Tian, Ying
    Li, Shanshan
    Liu, Tingzhi
    Liang, Chaoyong
    Lin, Jia Tian
    Shrestha, Prem Raj
    Xiao, Jian
    Zhang, Hongyu
    Cao, Yabing
    Zhai, Linzhu
    Lin, Tongyu
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] The role of high-dose chemotherapy in patients with Hodgkin's disease and non-Hodgkin's lymphoma
    Laport, GF
    Williams, SF
    SEMINARS IN ONCOLOGY, 1998, 25 (04) : 503 - 517
  • [5] High-dose sequential (HDS) chemotherapy as salvage treatment in 33 patients with refractory or relapsed non-Hodgkin's lymphoma.
    Tarella, C
    Caracciolo, D
    Gavarotti, P
    Corradini, P
    Zallio, F
    Castellino, C
    Pileri, A
    BLOOD, 1996, 88 (10) : 3881 - 3881
  • [6] HIGH-DOSE NITROSOUREA IN A CASE OF NON-HODGKIN LYMPHOMA
    SEGALINI, G
    DEMARIA, R
    GALLI, C
    CARINI, L
    LABIANCA, R
    HAEMATOLOGICA, 1984, 69 (05) : 639 - 640
  • [7] High-dose cyclophosphamide (Ctx) in CHOP regimen is safe and efficacious for agrressive non-Hodgkin lymphoma.
    Dann, EJ
    Drumea, K
    Haddad, N
    Hoffman, R
    Fineman, R
    Arbuv, L
    Rosenbaum, H
    Zuckerman, T
    Ben-Shachar, M
    Haim, N
    Epelbaum, R
    Rowe, JM
    BLOOD, 2001, 98 (11) : 347A - 347A
  • [8] Short high-dose CHOP chemotherapy for aggressive non-Hodgkin's lymphoma (NHL).
    Epelbaum, R
    Dann, E
    Drumea, K
    Haim, N
    Ben-Shahar, M
    Faraggi, D
    Rowe, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 584S - 584S
  • [9] High-dose chemotherapy and hemopoietic stem cell transplantation (ASCT) in poor-prognosis non Hodgkin's lymphoma
    Patti, C
    Cavallaro, A
    Tringali, S
    Indovina, A
    Santoro, A
    Costa, A
    Mistretta, A
    Cascio, L
    Pagano, M
    Rizzo, A
    Stella, M
    Scimè, R
    BONE MARROW TRANSPLANTATION, 2002, 29 : S86 - S86
  • [10] Overweight as a poor prognostic factor in non-Hodgkin's lymphoma patients undergoing high-dose chemotherapy and autograft.
    Tarella, C
    Gavarotti, P
    Caracciolo, D
    Argentino, C
    Corradini, P
    Zallio, F
    Novero, D
    Magnani, C
    Pileri, A
    BLOOD, 1998, 92 (10) : 373B - 373B
12345